Amgen announced July 27 that it plans to buy a privately held Bay Area biotech company called TeneoBio in an all-cash deal worth as much as $2.5 billion. The deal is expected to close in the second half of this year and calls for Amgen to pay $900 million up front for all outstanding shares Read More →
Westlake Park Place I, a five-building office campus in Westlake Village, sold recently for $80.8 million — the highest sale price for an office building in Ventura County in 2021. The buyer was a partnership between Amstar and Searles Property Group, and the seller was Invesco Real Estate. Westlake Park Place I started construction in Read More →
Darren Kettle, the executive director of the Ventura County Transportation Commission, is the next CEO of Metrolink, Southern California’s regional passenger railroad agency. The Metrolink Board of Directors named Kettle CEO in a vote on July 23. Metrolink serves six counties in Southern California, including Ventura County, with a focus on commuter rail service. Kettle Read More →
Takeda Pharmaceuticals, a Japanese company with major operations in the Conejo Valley, will expand its facility in Thousand Oaks, investing $126 million to build out the manufacturing operations to support new product lines. The Takeda team, alongside the mayor of Thousand Oaks, Claudia Bill-de la Peña, is scheduled to hold a groundbreaking ceremony for the Read More →
Sierra Bancorp reported record earnings boosted by lower loan and lease losses and improvements to the overall economy, the bank announced July 19. The parent company of Bank of the Sierra said it had $11.7 million in net income for the quarter ended June 30, or 76 cents per diluted share, compared to $8.3 million Read More →
Thousand Oaks-based Teledyne Technologies announced July 19 that its subsidiary, Teledyne Brown Engineering, was awarded a U.S. Navy contract for underwater drones worth as much as $39.2 million. The contract has a maximum base value of $27.4 million over five years, with five one-year option periods and a maximum value of $39.2 million if all Read More →
The U.S. Food and Drug Administration tagged Amgen with a letter July 7 that says the Thousand Oaks biotech firm made “misleading claims” in advertisements for its drug Neulasta, by suggesting it is more effective than biosimilar competitors. Neulasta is a prescription medication used to reduce infection risk from febrile neutropenia (a low level of Read More →